Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 2439Neoplasms 1845Carcinoma, Non-Small-Cell Lung 1615Prostatic Neoplasms 1315Colorectal Neoplasms 1149Lung Neoplasms 993Neoplasm Metastasis 838Multiple Myeloma 802Leukemia, Myeloid, Acute 778Ovarian Neoplasms 686Pancreatic Neoplasms 673Melanoma 669Squamous Cell Carcinoma of Head and Neck 592Carcinoma, Hepatocellular 571Recurrence 570Brain Neoplasms 531Glioblastoma 521Stomach Neoplasms 506Head and Neck Neoplasms 504Triple Negative Breast Neoplasms 474Lymphoma 463Uterine Cervical Neoplasms 457Carcinoma, Renal Cell 430Precursor Cell Lymphoblastic Leukemia-Lymphoma 421Lymphoma, Non-Hodgkin 392Endometrial Neoplasms 386Sarcoma 372Lymphoma, Follicular 358Urinary Bladder Neoplasms 356Lymphoma, Large B-Cell, Diffuse 356

Interventions

tislelizumab 1Taxes 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Fluorouracil 1Etoposide 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced and Metastatic Solid Tumors × 1 year × Clear all
NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

BeiGene

Phase 1 Completed
446 enrolled 49 charts
Other solid neoplasm

Locally Advanced and Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡